Long-term Outcome Recruiting Phase 4 Trials for Morphine (DB00295)

IndicationStatusPhase
DBCOND0081476 (Long-term Outcome)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03012971Dexmedetomidine Supplemented Analgesia and 2-Year Survival After Cancer SurgeryPrevention